Taiyen Biotech Co. Ltd. AI Stock Analysis
Taiyen Biotech Co. Ltd. (1737) AI Stock Analysis
Taiyen Biotech Co. Ltd.
(TWSE:1737)
The overall score of 63 reflects a company with a very strong, debt-free balance sheet and a high dividend yield, which are its primary strengths. These positive factors are significantly counterbalanced by a weak technical trend and, most importantly, a concerning decline in free cash flow that questions the quality of reported earnings. The stock offers income appeal but faces near-term headwinds from poor momentum and cash flow pressures.
Taiyen Biotech Co. Ltd. (1737) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- TWD 5.95B
- Dividend Yield
- 4.71%
- Average Volume (3M)
- 293.10K
- Price to Earnings (P/E)
- 15.7
- Beta (1Y)
- 0.05
- Revenue Growth
- -2.24%
- EPS Growth
- 12.99%
- Country
- TW
- Employees
- 479
- Sector
- General
- Sector Strength
- 55
- Industry
- Household & Personal Products
Taiyen Biotech Co. Ltd. Business Overview & Revenue Model
Company Description
Established in 1952 and headquartered in Tainan, Taiwan, Taiyen Biotech Co., Ltd. is a multifaceted enterprise engaged in the global production and distribution of salt-based goods. The company offers a wide-ranging portfolio that includes various sa...
Taiyen Biotech Co. Ltd. Financial Statement Overview
Summary
The company shows a solid financial profile with a fortress-like balance sheet (debt-to-equity of 0.03) and improving profitability, as net margins expanded to 12.1%. However, this is offset by a significant and sustained decline in free cash flow, which fell 38.5% in the latest period, creating a divergence between accounting profits and cash generation.
Income Statement
72PositiveBalance Sheet
85Very PositiveCash Flow
55Neutral| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.19B | 3.31B | 3.24B | 3.41B | 3.61B | 4.10B |
| Gross Profit | 1.25B | 1.34B | 1.32B | 1.21B | 1.28B | 1.37B |
| EBITDA | 676.56M | 720.11M | 657.96M | 530.52M | 640.00M | 718.84M |
| Net Income | 389.53M | 399.87M | 371.52M | 300.39M | 426.70M | 393.23M |
Balance Sheet | ||||||
| Total Assets | 8.38B | 8.26B | 8.38B | 8.32B | 8.21B | 8.47B |
| Cash, Cash Equivalents and Short-Term Investments | 1.97B | 1.75B | 1.94B | 1.84B | 1.89B | 2.08B |
| Total Debt | 228.22M | 223.20M | 311.54M | 317.19M | 268.36M | 506.55M |
| Total Liabilities | 1.67B | 1.45B | 1.71B | 1.77B | 1.55B | 1.95B |
| Stockholders Equity | 6.71B | 6.81B | 6.66B | 6.49B | 6.52B | 6.36B |
Cash Flow | ||||||
| Free Cash Flow | 278.67M | 173.60M | 352.51M | 109.41M | 334.09M | 209.26M |
| Operating Cash Flow | 583.78M | 473.77M | 660.12M | 454.54M | 580.69M | 600.08M |
| Investing Cash Flow | -351.44M | -310.03M | -287.76M | -339.30M | -229.63M | -351.38M |
| Financing Cash Flow | -277.16M | -365.91M | -266.52M | -199.22M | -547.98M | -28.44M |
Taiyen Biotech Co. Ltd. Peers Comparison
Overall Rating
TW:420573Outperform
TW:173464Neutral
TW:173763Neutral
TW:122558Neutral
TW:120150Neutral
TW:121849Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 73Outperform | TWD 6.38B | 15.72 | ― | 5.36% | 0.29% | -7.81% | |
| 64Neutral | TWD 6.06B | 17.27 | ― | 3.14% | 2.44% | -3.96% | |
| 63Neutral | TWD 5.95B | 15.74 | ― | 4.71% | -2.24% | 12.99% | |
| 58Neutral | TWD 6.18B | 127.50 | ― | 0.49% | -4.25% | -119.80% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 50Neutral | TWD 5.97B | 26.02 | ― | 1.78% | -4.41% | -18.82% | |
| 49Neutral | TWD 6.30B | -7.19 | ― | 10.19% | -11.07% | -237.67% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TW:1737 | Taiyen Biotech Co. Ltd. | 29.75 | -0.63 | -2.08% | |
| TW:1201 | Wei Chuan Foods Corp. | 11.80 | -2.95 | -20.00% | |
| TW:1218 | Taisun Enterprise Co., Ltd. | 12.95 | -4.00 | -23.59% | |
| TW:1225 | Formosa Oilseed Processing Co., Ltd. | 25.50 | -4.90 | -16.12% | |
| TW:1734 | Sinphar Pharmaceutical Co. Ltd. | 30.05 | 2.12 | 7.57% | |
| TW:4205 | Chung Hwa Food Industrial Co., Ltd. | 65.30 | -15.05 | -18.73% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 09, 2026
